A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patientsA single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients, Published online: 16 January 2019; doi:10.1038/s41397-019-0072-6A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
Source: The Pharmacogenomics Journal - Category: Drugs & Pharmacology Authors: C écile Luxembourger Adeline Ruyssen-Witrand Chayma Ladhari C écile Rittore Yannick Degboe Jean-Francis Maillefert Philippe Gaudin Hubert Marotte Daniel Wendling Christian Jorgensen Alain Cantagrel Arnaud Constantin Delphine Nigon Isabelle Touitou Jacqu Source Type: research
More News: Actemra | Arthritis | Drugs & Pharmacology | Luxembourg Health | Rheumatoid Arthritis | Rheumatology